(Reuters) - South Korea's Samsung Group is in talks to buy U.S. drugmaker Biogen Inc (BIIB.O), Korea Economic Daily reported on Wednesday, citing investment banking sources. The report said Biogen approached Samsung to buy its shares, which could be valued at more than $42 billion. The...